Literature DB >> 8865317

Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs.

J Voorspoels1, J P Remon, W Eechaute, W De Sy.   

Abstract

PURPOSE: As the oral bioavailability of testosterone is very low because of its high first pass effect, buccal administration might present a viable alternative. In this study a buccal bioadhesive tablet was used in order to sustain the delivery and bypass the liver.
METHODS: Testosterone and testosterone acetate, propionate, enanthate and decanoate were investigated. The influence of the concentration of testosterone (10-50%) and testosterone esters (30%) on in vitro bioadhesion was investigated. The absolute (i.v.) and relative (oral) bioavailability of 60 mg testosterone or an equivalent amount of testosterone ester was determined in castrated male dogs.
RESULTS: Both the in vitro detachment force and the work of adhesion decreased gradually with an increasing amount of testosterone and for an increasing chain length of the esters, except in the case of testosterone enanthate. The in vivo results revealed that the bioavailability of testosterone was significantly higher (p < 0.05) than that of the esters, which is probably due to the lower solubility of the esters. The mean absolute bioavailability of testosterone from the bioadhesive tablet was 14.1%, while the mean relative bioavailability was 1370%. The buccal administration of testosterone via the bioadhesive tablet allowed the maintenance of the plasma level at above 3 ng/ml for 15 to 24 h.
CONCLUSIONS: Buccal absorption of testosterone was significantly higher than that of its esters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865317     DOI: 10.1023/a:1016072522151

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel.

Authors:  S Bouckaert; H Schautteet; R A Lefebvre; J P Remon; R van Clooster
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring.

Authors:  J H Proost; D K Meijer
Journal:  Comput Biol Med       Date:  1992-05       Impact factor: 4.589

3.  Age-related changes in plasma dehydroepiandrosterone sulphate, cortisol, testosterone and free testosterone circadian rhythms in adult men.

Authors:  V Montanini; M Simoni; G Chiossi; G F Baraghini; A Velardo; E Baraldi; P Marrama
Journal:  Horm Res       Date:  1988

4.  Buccal drug absorption. II: In vitro diffusion across the hamster cheek pouch.

Authors:  K W Garren; A J Repta
Journal:  J Pharm Sci       Date:  1989-02       Impact factor: 3.534

5.  High lipophilicity decreases drug transport across intestinal epithelial cells.

Authors:  P Wils; A Warnery; V Phung-Ba; S Legrain; D Scherman
Journal:  J Pharmacol Exp Ther       Date:  1994-05       Impact factor: 4.030

6.  Influence of the application site on bioadhesion and slow-release characteristics of a bioadhesive buccal slow-release tablet of miconazole.

Authors:  S Bouckaert; R A Lefebvre; F Colardyn; J P Remon
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Therapeutic effectiveness of oral testosterone.

Authors:  S G Johnsen; E P Bennett; V G Jensen
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

8.  A model for steroid transport across biological membranes.

Authors:  A H Beckett; M E Pickup
Journal:  J Pharm Pharmacol       Date:  1975-04       Impact factor: 3.765

9.  In-vitro bioadhesion of a buccal, miconazole slow-release tablet.

Authors:  S Bouckaert; J P Remon
Journal:  J Pharm Pharmacol       Date:  1993-06       Impact factor: 3.765

10.  Human transbuccal absorption of diclofenac sodium from a prototype hydrogel delivery device.

Authors:  J Cassidy; B Berner; K Chan; V John; S Toon; B Holt; M Rowland
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

View more
  1 in total

Review 1.  Testosterone hormone replacement therapy: state-of-the-art and emerging technologies.

Authors:  Marie-Laure Leichtnam; Hervé Rolland; Patrick Wüthrich; Richard H Guy
Journal:  Pharm Res       Date:  2006-06-09       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.